NEW MJ NEWS

AbbVie to Host First-Quarter 2023 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2023 financial results on Thursday, April 27, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2023-earnings-conference-call-301788964.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MCIG Announces Preliminary Record Numbers for Third Quarter

mCig, Inc. Announces Preliminary Record Numbers for Third Quarter   mCig, Inc.…

Tetra Bio-Pharma Inc. (TBPMF) Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma

Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma Tetra Bio-Pharma…

American Premium Water Corporation (HIPH) Announces Financing Arrangement at a .40 Valuation

American Premium Water Corp. (HIPH) Announces Financing Arrangement at a .40 Valuation…

$PMCB Clinical Milestones in 2015

Clinical Milestones Abound for PharmaCyte Biotech in 2015 BALTIMORE, Mar. 30, 2015…